Speranza Therapeutics announces value-based program for opioid detox facilities program vows to reduce costly facility against Medical Advice (AMA) leave rates
August 4, 2021
August 4, 2021
August 3, 2021
August 3, 2021
July 27, 2021
July 27, 2021
July 27, 2021
July 27, 2021
July 22, 2021
July 19, 2021
December 4, 2025
The study reinforces that ME is a complex multisystemic condition with a clear genetic basis and lays the foundation for future clinical trials that c...
October 30, 2025
Lonza to acquire Redberry SAS, an innovative company specializing in rapid microbiology testing solutions Acquisition to include Red One™ solid-phase ...
October 29, 2025
Collaboration aims to deliver rapid, lab-quality testing to communities worldwide – making precision health more accessible EazeBio today announced a ...
Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225